iShares Biotechnology ETF
IBB
IBB
288 hedge funds and large institutions have $4.56B invested in iShares Biotechnology ETF in 2014 Q1 according to their latest regulatory filings, with 55 funds opening new positions, 90 increasing their positions, 96 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
288
Holders Change
+11
Holders Change %
+3.97%
% of All Funds
8.32%
Holding in Top 10
20
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+5.26%
% of All Funds
0.58%
New
55
Increased
90
Reduced
96
Closed
43
Calls
$614M
Puts
$735M
Net Calls
-$122M
Net Calls Change
+$144M
Top Buyers
| 1 |
Citigroup
New York
|
$628M |
| 2 |
Morgan Stanley
New York
|
$461M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$287M |
| 4 |
Mirae Asset Global Investments
Seoul,
South Korea
|
$165M |
| 5 |
Goldman Sachs
New York
|
$713M |
